LAVA Medtech Acquisition (LVACU) Stock Price, News & Analysis

Company Overview

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.

Key Stats

• Today's Range: $10.40 to $10.40
• 50-Day Range: $10.40 to $10.43
• 52-Week Range: $9.92 to $10.68
• Volume: 2 shs
• Average Volume: 4,708 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LVACU Stock Analysis - Frequently Asked Questions

When did LAVA Medtech Acquisition IPO?

LAVA Medtech Acquisition (LVACU) raised $100 million in an initial public offering (IPO) on Wednesday, October 27th 2021. The company issued 10,000,000 shares at $10.00 per share.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LVACU
• CIK: 1855450
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: 2,021
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A